Mette H Lauritzen Selected Research

Biomarkers (Surrogate Marker)

1/2019

Reversed metabolic reprogramming as a measure of cancer treatment efficacy in rat C6 glioma model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mette H Lauritzen Research Topics

Disease

2	Neoplasms (Cancer) 01/2019 - 01/2015
1	Glioma (Gliomas) 01/2019
1	Glioblastoma (Glioblastoma Multiforme) 01/2019
1	Breast Neoplasms (Breast Cancer) 01/2015

Drug/Important Bio-Agent (IBA)

2	Pyruvic Acid (Pyruvate)IBA 01/2019 - 01/2015
2	Pharmaceutical PreparationsIBA 01/2019 - 01/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019
1	Bicarbonates (Hydrogen Carbonate)IBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2019
1	imidazole mustard (BIC)IBA 01/2019
1	Estrogens (Estrogen)FDA Link 01/2015
1	Tamoxifen FDA LinkGeneric 01/2015